The effect of total intravenous anesthesia and prophylactic ramosetron on postoperative nausea and vomiting after thyroidectomy

Trial Profile

The effect of total intravenous anesthesia and prophylactic ramosetron on postoperative nausea and vomiting after thyroidectomy

Completed
Phase of Trial: Phase II

Latest Information Update: 31 May 2017

At a glance

  • Drugs Ramosetron (Primary)
  • Indications Postoperative nausea and vomiting
  • Focus Therapeutic Use
  • Most Recent Events

    • 10 Dec 2015 Primary endpoint of postoperative nausea and vomiting has been met, according to results published in the Journal of International Medicine Research.
    • 10 Dec 2015 Status changed from active, no longer recruiting to completed, according to results published in the Journal of International Medical Research.
    • 10 Dec 2015 Results published in the Journal of International Medical Research
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top